Navigation Links
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Date:9/3/2007

KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Schering-Plough/Merck Pharmaceuticals (SPM) today announced that the New Drug Application filing for loratadine/montelukast has been accepted by the U.S. Food and Drug Administration (FDA) for standard review.

Schering-Plough/Merck Pharmaceuticals is seeking U.S. marketing approval of loratadine/montelukast for treatment of allergic rhinitis symptoms in patients who want relief from nasal congestion. If approved the medicine would be marketed as a prescription treatment by Schering-Plough/Merck Pharmaceuticals, a joint venture between Schering-Plough Corporation (NYSE: SGP) and Merck & Co., Inc. (NYSE: MRK).

The medicine is a single tablet that contains the active ingredients of CLARITIN (R) (loratadine) and SINGULAIR (R) (montelukast sodium), both of which are indicated for the relief of symptoms of allergic rhinitis.

About Allergic Rhinitis

Allergic rhinitis affects more than 50 million people in the United States (1,2) and accounts for more than 14 million physician office visits each year.(3) It is one of the most costly chronic illnesses in the United States (4) and is estimated to cause 100 million days of lost work per year.(5)

There are two forms of allergic rhinitis: seasonal and perennial. Seasonal allergic rhinitis occurs only during certain times of the year and is commonly caused by allergies to tree, grass and weed pollen (often referred to as "hay- fever"). Per
'/>"/>

SOURCE Schering-Plough/Merck Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
(Date:7/1/2015)... ... 01, 2015 , ... “Well-meaning social policy often has unintended ... FIU’s School of International and Public Affairs. , The researchers examined ... National Survey on Drug Use and Health, which is a nationally representative survey ...
(Date:7/1/2015)... Columbus, OH (PRWEB) , ... July 01, 2015 , ... ... pleased to announce Dr. Leslie King has been named Dean of the ... role as Dean, Dr. King will promote and support the vision and mission of ...
(Date:7/1/2015)... New York (PRWEB) , ... July 01, 2015 , ... Author Francesca Camp ... surgery fell into her lap, so too did her support of the practice; a terrible ... , In her new book, “Do I Need It ? (And What if ...
Breaking Medicine News(10 mins):Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2
... , ... Dr. David J. Goldberg presents findings on the future of facial fillers, the Liquid ... , ... 19, 2010 -- Renowned dermatologist Dr. David J. Goldberg presented findings on the future ...
... insight into various illnesses , FRIDAY, Feb. 19 (HealthDay ... in protecting the intestinal tract from bacterial infection and ... levels of the protein -- granulocyte-macrophage colony-stimulating factor (GM-CSF) ... illness caused by pathogens such as E. coli and ...
... of aging in the brain , FRIDAY, Feb. 19 (HealthDay News) ... Elizabeth Reed felt she still had more to offer. , So ... elementary students in low-income schools with seniors who serve as tutors ... hours a week at a school in Dorchester, Mass., says helping ...
... , ... ... ... ...
... , ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques 2Health News:The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques 3Health News:When Seniors Tutor Kids, They Sharpen Their Own Minds As Well 2Health News:When Seniors Tutor Kids, They Sharpen Their Own Minds As Well 3Health News:Health Groups Ask Supreme Court to Authorize Financial Penalties on Tobacco Companies for Decades of Wrongdoing 2Health News:Health Groups Ask Supreme Court to Authorize Financial Penalties on Tobacco Companies for Decades of Wrongdoing 3Health News:The SCOOTER Store Donates Scooters to WWII Veterans to Visit Jamestown Memorial 2Health News:The SCOOTER Store Donates Scooters to WWII Veterans to Visit Jamestown Memorial 3Health News:The SCOOTER Store Donates Scooters to WWII Veterans to Visit Jamestown Memorial 4Health News:The SCOOTER Store Donates Scooters to WWII Veterans to Visit Jamestown Memorial 5Health News:The SCOOTER Store Donates Scooters to WWII Veterans to Visit Jamestown Memorial 6Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 2Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 3
(Date:7/1/2015)... 1, 2015 Prismic Pharmaceuticals, Inc., a specialty ... foods, today announced the election of Joseph J. ... its Board of Directors. Commenting on the ... Moriarty , Chairman and CEO of Prismic, stated, "We ... Martin Simonetti have accepted our invitation to join ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics Corporation ... and marketer of rehabilitation and physical therapy products, ... private placement financing led by affiliates of Prettybrook ... investor focused on the healthcare industry. The financing ... growth and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... , July 1, 2015 Qiming Venture ... to Managing Partner effective immediately. William ... has lead and participated in many Qiming healthcare deals, ... in the Chinese market. Qiming, s success in healthcare ... he has distinguished himself with his outstanding advocacy and ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2
... JOSE, Calif., Aug. 17 SI-BONE, Inc. (San Jose, California), ... a minimally invasive surgical (MIS) device to treat the sacroiliac ... in financing for expansion of clinical and commercial operations. The ... Palo Alto, California. The primary purposes of ...
... MD Buyline reports that Elekta,s linear accelerators ... treatment planning systems received the highest user satisfaction ... industry. Vendors are rated on ... satisfaction with system performance, system reliability, system installation/implementation, ...
Cached Medicine Technology:SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures 2SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures 3Elekta Earns Top Customer Marks from MD Buyline for 2nd Quarter 2010 2Elekta Earns Top Customer Marks from MD Buyline for 2nd Quarter 2010 3
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: